About the Rome IV Criteria for Biliary Pain, Functional Gallbladder Disorder and Functional Biliary Sphincter of Oddi Disorder
Five features and a location establish biliary pain; two test results then decide the subtype. The pain must be epigastric and/or right upper quadrant and must build to a steady level lasting 30 minutes or longer, occur at different intervals rather than daily, be severe enough to interrupt daily activities or prompt an emergency visit, be not significantly related to bowel movements, and be not significantly relieved by postural change or acid suppression. With no gallstones or structural pathology and no biochemical or ductal abnormality, this is functional gallbladder disorder. With elevated liver enzymes **or** a dilated bile duct — Rome IV specifies one or the other, but not both — it is functional biliary sphincter of Oddi disorder.
Formula
Biliary pain = epigastric/RUQ location AND all 5 features
E1a functional gallbladder disorder = biliary pain AND no stones/structural pathology AND no enzyme or duct abnormality
E1b functional biliary SOD = biliary pain AND no stones/structural pathology AND (elevated enzymes XOR dilated duct)- All 5 features
- Every one is required. Four of five does not establish biliary pain, and the criteria are written this way deliberately to restrict who proceeds to intervention.
- XOR
- Rome IV's exact wording is 'elevated liver enzymes or dilated bile duct, but not both'. This is the only exclusive-or in the entire Rome IV document, and both markers together places the patient outside the criteria.
- The five pain features are conjunctive — all required, not a majority.
- 'Not significantly' is quantified at under 20% of episodes for both the bowel-movement and postural/acid-suppression criteria.
- Supportive features — nausea, vomiting, radiation to the back or infrascapular region, waking from sleep — strengthen the impression but are not required.
- For functional gallbladder disorder, a low ejection fraction on scintigraphy and normal liver enzymes, conjugated bilirubin and amylase/lipase are supportive rather than diagnostic.
- For functional biliary SOD, normal amylase and lipase, abnormal sphincter of Oddi manometry and hepatobiliary scintigraphy are supportive.
- Rome IV abandoned the older type I/II/III sphincter of Oddi dysfunction classification; the former 'type III' — biliary pain with no objective abnormality — no longer supports intervention.
Interpreting the result
Meeting the biliary pain criteria without any structural or biochemical abnormality gives functional gallbladder disorder, and here the honest position is that the evidence for cholecystectomy is contested. A low ejection fraction on scintigraphy is supportive but predicts response less reliably than was once believed, and a substantial proportion of patients have persistent pain after surgery. That uncertainty belongs in the conversation before the operation rather than after it, and functional dyspepsia — which overlaps considerably in symptoms and is treated medically — should be excluded carefully first. Where an objective marker is present, the diagnosis is functional biliary sphincter of Oddi disorder, and the threshold for intervention should be high: sphincter of Oddi manometry and ERCP carry post-procedure pancreatitis rates among the highest of any indication. The both-markers case is worth pausing on — elevated enzymes together with a dilated duct falls outside Rome IV's criteria and should prompt further imaging for a structural cause rather than a functional label.
| Score | Band | What it means | Action |
|---|---|---|---|
| Biliary pain, no stones, no markers | Functional gallbladder disorder (E1a) | Biliary pain without structural pathology or biochemical abnormality; low ejection fraction on scintigraphy is supportive | Discuss cholecystectomy with explicit uncertainty; exclude functional dyspepsia carefully first |
| Biliary pain, no stones, enzymes OR dilated duct | Functional biliary sphincter of Oddi disorder (E1b) | An objective marker implicating the sphincter, without structural abnormality | High threshold for ERCP and sphincterotomy given post-procedure pancreatitis risk; manage in a high-volume centre |
| Biliary pain, enzymes AND dilated duct | Outside the criteria | Rome IV specifies one marker or the other but not both — the combination suggests an unidentified structural cause | Further imaging rather than a functional label |
| Fewer than 5 pain features | Criteria not met | The pain is not biliary by Rome IV definition | Assess for functional dyspepsia, reflux or a bowel disorder depending on which feature failed |
What the Biliary Pain (Rome IV) needs (9 inputs)
- Pain located in the epigastrium and/or right upper quadrant
- Supportive features, which are not required, include nausea and vomiting, radiation to the back or right infrascapular region, and waking the patient from sleep.
- Builds up to a steady level and lasts 30 minutes or longer
- Biliary pain plateaus rather than colicking. The term 'biliary colic' is a misnomer that persists — true colicky, waxing-and-waning pain argues against this diagnosis.
- Occurs at different intervals, not daily
- Daily pain is not biliary. This criterion alone excludes a large group of patients who are otherwise considered for cholecystectomy.
- Severe enough to interrupt daily activities or lead to an emergency department visit
- A severity threshold, and a high one. Mild recurrent discomfort does not meet it.
- Not significantly (< 20%) related to bowel movements
- Pain relieved by defecation points to a bowel disorder. Rome IV quantifies 'not significantly' as under 20% of episodes.
- Not significantly (< 20%) relieved by postural change or acid suppression
- Relief with a proton pump inhibitor points to functional dyspepsia or reflux; relief with position change points elsewhere again.
- Absence of bile duct stones and other structural abnormalities
- Required for both functional subtypes. Where structural pathology is present, neither applies.
- Elevated liver enzymes
- One of the two markers for functional biliary sphincter of Oddi disorder — and Rome IV requires this OR a dilated duct, but explicitly not both.
- Dilated bile duct
- The alternative marker. Both markers together falls outside the criteria and suggests a structural cause not yet identified.
What it returns
- Whether biliary pain criteria are met
- Location plus all five features. This is the gate — no subtype applies without it.
- Subtype
- Functional gallbladder disorder, functional biliary sphincter of Oddi disorder, structural pathology present, or the both-markers case that falls outside the criteria.
How it is calculated
The structure separates a symptom definition from two diagnoses, and that separation is the point. Biliary pain is defined first and strictly, because the differential for upper abdominal pain is wide and most of it is not biliary — the five features together describe an episodic, severe, plateauing pain that does not behave like dyspepsia, reflux or a bowel disorder. Only once that is established does the question of mechanism arise, and it is settled by objective findings rather than by the pain itself: nothing about the character of biliary pain distinguishes a gallbladder problem from a sphincter one. Rome IV's move away from the old type I/II/III classification reflects accumulated evidence, particularly the EPISOD trial, that patients with biliary-type pain and no objective abnormality do not benefit from sphincterotomy — so the criteria now require a marker before the sphincter can be implicated at all.
Facts & figures
| Feature | If absent, consider |
|---|---|
| Builds to a steady level, lasts ≥ 30 minutes | Brief or colicky pain — not biliary; consider bowel or musculoskeletal causes |
| Occurs at different intervals, not daily | Daily pain — functional dyspepsia or CAPS |
| Severe enough to interrupt activities | Milder recurrent discomfort — functional dyspepsia |
| Not significantly related to bowel movements | Relief on defecation — irritable bowel syndrome |
| Not relieved by posture or acid suppression | Response to a PPI — reflux disease or functional dyspepsia |
All five are required. The criteria function as a filter on who proceeds toward intervention, and each failed feature points somewhere specific rather than merely excluding.
| Enzymes | Dilated duct | Rome IV result |
|---|---|---|
| Normal | No | Functional gallbladder disorder (E1a) |
| Elevated | No | Functional biliary SOD (E1b) |
| Normal | Yes | Functional biliary SOD (E1b) |
| Elevated | Yes | Outside the criteria — Rome IV says one or the other, not both |
This is the only exclusive-or in Rome IV. The both-present case is not a stronger version of E1b — it falls outside the definition and warrants a search for structural disease.
Evidence
Derivation — Rome Foundation, gallbladder and sphincter of Oddi committee
2016Consensus criteria from the Rome IV committee on gallbladder and sphincter of Oddi disorders, published in Gastroenterology in 2016.
Consensus-derived. The substantive change from Rome III was abandoning the type I/II/III sphincter of Oddi dysfunction classification and requiring an objective marker — elevated enzymes or a dilated duct — before functional biliary sphincter of Oddi disorder can be diagnosed.
EPISOD trial — sphincterotomy without objective abnormality
2014Randomised trial of endoscopic sphincterotomy versus sham in patients with post-cholecystectomy pain and suspected sphincter of Oddi dysfunction without objective abnormalities.
Found no benefit from sphincterotomy on pain-related disability, and the results directly informed Rome IV's decision to require an objective marker and to retire the former type III category.
How it compares
Biliary Pain (Rome IV) vs Functional dyspepsia
Substantial symptom overlap, opposite management — dyspepsia is treated medically and biliary pain leads toward surgery, so getting this wrong sends a patient to theatre unnecessarily.
Epigastric pain syndrome and biliary pain both produce recurrent upper abdominal pain, and Rome IV's dyspepsia criteria explicitly note that the pain 'does not fulfil biliary pain criteria'. The discriminating features are in the biliary criteria themselves: daily pain, mild pain, pain relieved by acid suppression, and pain related to bowel movements all indicate dyspepsia rather than a biliary cause. Because functional dyspepsia responds to a proton pump inhibitor trial and to neuromodulators, excluding it properly before cholecystectomy is the single most useful step in avoiding an operation that will not help.
Biliary Pain (Rome IV) vs Sphincter of Oddi dysfunction types I, II and III
Rome IV retired this classification — the former type III, biliary pain with no objective abnormality, no longer supports intervention after the EPISOD trial.
The old scheme graded suspected sphincter dysfunction by the presence of enzyme elevation and duct dilatation, with type III being pain alone. EPISOD randomised patients with post-cholecystectomy pain and no objective abnormality to sphincterotomy or sham and found no benefit on pain-related disability, while the procedure carried substantial pancreatitis risk. Rome IV responded by requiring an objective marker for functional biliary sphincter of Oddi disorder at all, which effectively removes the type III group from consideration for intervention and redirects them to medical management.
Biliary Pain (Rome IV) vs Functional pancreatic sphincter of Oddi disorder
Different presentation and a far higher evidential bar — the pancreatic disorder requires documented recurrent pancreatitis, not pain alone.
Functional pancreatic sphincter of Oddi disorder is defined by documented recurrent episodes of pancreatitis with other aetiologies excluded, a negative endoscopic ultrasound, and abnormal sphincter manometry — four criteria, every one requiring an investigation. Biliary sphincter disorder is defined by biliary pain plus a single biochemical or ductal marker. The distinction matters because the pancreatic diagnosis rests on objectively documented episodes of pancreatitis rather than on a pain description, and the intervention carries a correspondingly high risk that the stricter criteria are designed to justify.
Pearls & pitfalls
- All five pain features are required. Four of five does not establish biliary pain, and the strictness is deliberate — it limits who proceeds toward an irreversible intervention.
- 'Biliary colic' is a misnomer. The pain builds to a steady plateau; genuinely colicky waxing-and-waning pain argues against the diagnosis.
- Daily pain is not biliary. This single criterion excludes a large group otherwise considered for cholecystectomy.
- Relief with a proton pump inhibitor points to functional dyspepsia or reflux and fails the criteria — Rome IV quantifies 'not significantly' at under 20% of episodes.
- Elevated enzymes AND a dilated duct together falls outside the criteria. It is not a stronger E1b; it suggests a structural cause not yet found.
- Sphincter of Oddi dysfunction type III no longer supports intervention. The EPISOD trial found sphincterotomy no better than sham in that group.
- A low gallbladder ejection fraction is supportive, not diagnostic, and predicts response to cholecystectomy less reliably than it is often credited with.
- A meaningful proportion of patients have persistent pain after cholecystectomy for functional gallbladder disorder. That belongs in the consent conversation.
- ERCP with manometry in this population carries one of the highest post-procedure pancreatitis rates of any indication — the threshold should be correspondingly high.
- Exclude functional dyspepsia carefully. The symptom overlap is considerable and it is treated medically rather than surgically.
Critical actions
- Check all five pain features explicitly rather than accepting a general impression of biliary-type pain.
- Exclude gallstones, microlithiasis and structural pathology with good-quality imaging, including endoscopic ultrasound where suspicion persists.
- Measure liver enzymes during or shortly after an episode, since transient elevation is easily missed between attacks.
- Assess and exclude functional dyspepsia and reflux disease before attributing symptoms to the biliary tree.
- Where both elevated enzymes and a dilated duct are present, pursue further imaging rather than applying a functional label.
- Discuss the contested evidence for cholecystectomy in functional gallbladder disorder explicitly before operating.
- Reserve ERCP and sphincterotomy for patients meeting E1b criteria, and refer to a high-volume centre given the pancreatitis risk.
- Do not offer sphincterotomy to patients with biliary-type pain and no objective abnormality.
Why this score exists
The committee's most consequential act was retiring sphincter of Oddi dysfunction type III — biliary-type pain with no objective abnormality — as an indication for intervention. That category had generated a large volume of ERCP and sphincterotomy in patients with normal enzymes and normal ducts, and the EPISOD trial showed the procedure performed no better than sham while carrying a substantial risk of pancreatitis. Rome IV's response was to require an objective marker before the sphincter can be implicated at all. The exclusive-or in the E1b criteria comes from the same instinct: the committee wanted a marker specific enough to justify a high-risk procedure, and reasoned that a patient with both elevated enzymes and a dilated duct is more likely to have a structural lesion that has not been found than a functional sphincter disorder. Both decisions narrow the diagnosis deliberately, and both were made to keep patients out of theatre.
About the creator
First author, Rome IV gallbladder and sphincter of Oddi committee; EPISOD principal investigator
Chaired the Rome IV committee and led the EPISOD trial whose results reshaped the sphincter of Oddi criteria.
Co-author, Rome IV gallbladder and sphincter of Oddi committee
Co-authored the chapter defining biliary pain and its functional subtypes.
Co-author; longstanding work on biliary motility disorders
Contributed much of the earlier framework on gallbladder and sphincter of Oddi function that Rome IV revised.
Limitations
- The five pain features rest entirely on history, and patients describe episodic severe pain inconsistently in retrospect.
- Liver enzyme elevation in this context is transient and easily missed if bloods are taken between episodes rather than during one.
- The evidence for cholecystectomy in functional gallbladder disorder is contested, and gallbladder ejection fraction predicts response poorly.
- The exclusive-or in the E1b criteria is a consensus judgement rather than an empirically derived rule.
- Sphincter of Oddi manometry is available in few centres and itself carries significant procedural risk.
- Built by committee agreement rather than from outcome data, and the objective-marker requirement was chosen to restrict intervention rather than because it was shown to select responders.
- Considerable overlap with functional dyspepsia, which the criteria acknowledge but do not help resolve beyond the acid-suppression feature.
- Says nothing about management of patients who meet biliary pain criteria but have no objective abnormality — a common and unsatisfying position.
If you are the patient
Biliary pain is a particular kind of upper abdominal pain that doctors associate with the gallbladder or the bile ducts. To count as biliary pain it has to fit a specific pattern: felt in the upper middle or upper right abdomen, building up to a steady level and lasting at least half an hour, coming in separate episodes rather than every day, severe enough to stop you doing things or take you to hospital, not linked to opening your bowels, and not relieved by antacids or by changing position. All of those have to fit — if your pain is daily, mild, or settles with indigestion tablets, it is probably coming from somewhere else, most often the stomach, and that is treated with medicines rather than surgery. If the pattern does fit and scans show no gallstones, there are two possibilities. One involves the gallbladder itself; removing it is sometimes offered, but it is worth knowing that the evidence is genuinely mixed and a meaningful number of people still have pain afterwards — so ask about that before deciding. The other involves the muscle valve where the bile duct enters the bowel, and is only considered when blood tests or scans show a specific abnormality. The test and treatment for that carry a real risk of causing pancreatitis, so it is reserved for clear cases and specialist centres.
Frequently asked questions
What are the Rome IV criteria for biliary pain?#
Pain in the epigastrium and/or right upper quadrant with all of: builds up to a steady level and lasts 30 minutes or longer; occurs at different intervals, not daily; severe enough to interrupt daily activities or lead to an emergency department visit; not significantly (under 20%) related to bowel movements; and not significantly (under 20%) relieved by postural change or acid suppression.
What is the difference between functional gallbladder disorder and biliary SOD?#
Both require biliary pain and the absence of stones or structural abnormality. Functional gallbladder disorder has no biochemical or ductal abnormality — a low ejection fraction on scintigraphy is supportive. Functional biliary sphincter of Oddi disorder requires either elevated liver enzymes or a dilated bile duct, but explicitly not both.
Why does Rome IV say 'elevated enzymes or dilated duct, but not both'?#
It is the only exclusive-or in the entire Rome IV document, and the reasoning is that a patient with both findings is more likely to have a structural lesion not yet identified than a functional sphincter disorder. The combination therefore falls outside the criteria and should prompt further imaging rather than a functional label — it is not a stronger version of the diagnosis.
Is 'biliary colic' an accurate term?#
No, and the Rome IV criteria make that clear. Biliary pain builds to a steady plateau and stays there for 30 minutes or longer; it does not wax and wane in the colicky pattern the name implies. Genuinely colicky pain argues against a biliary cause, which is a useful discriminator that the traditional terminology obscures.
Does sphincter of Oddi dysfunction type III still exist?#
Not as an indication for intervention. Rome IV retired the type I/II/III classification, and the former type III — biliary-type pain with no objective abnormality — no longer supports sphincterotomy. The EPISOD trial randomised exactly that group to sphincterotomy or sham and found no benefit on pain-related disability, while the procedure carried substantial pancreatitis risk.
Does cholecystectomy help functional gallbladder disorder?#
The evidence is genuinely contested. A low gallbladder ejection fraction on scintigraphy is a supportive criterion but predicts response less reliably than it was once credited with, and a substantial proportion of patients have persistent pain after surgery. The uncertainty belongs in the discussion before the operation, and excluding functional dyspepsia carefully first is the most useful step in avoiding an unhelpful cholecystectomy.
How does biliary pain differ from functional dyspepsia?#
Rome IV's dyspepsia criteria state explicitly that the pain 'does not fulfil biliary pain criteria'. The discriminators are within the biliary features: daily pain, mild pain, relief with acid suppression and a relationship to bowel movements all point to dyspepsia. The distinction matters because dyspepsia is treated medically while a biliary label leads toward surgery.
When should liver enzymes be checked?#
During or shortly after an episode. Enzyme elevation in functional biliary sphincter of Oddi disorder is transient, and bloods taken between attacks are frequently normal — which can wrongly place a patient in the gallbladder category. If the history is convincing and enzymes are normal between episodes, arranging for them to be checked during the next attack is worthwhile.